• The role of artificial intelligence in MRI-driven active surveillance in prostate cancer.
  Sushentsev Nikita et al. Nature reviews. Urology 2022
• An appraisal of genetic testing for prostate cancer susceptibility
  A Finch et al, NPJ Precision Oncology, June 22, 2022
• Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer.
  Guin Sunny et al. JCO clinical cancer informatics 2022 6e2200010
• Predicting biochemical recurrence of prostate cancer with artificial intelligence.
  Pinckaers Hans et al. Communications medicine 2022 264
• Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
  Giri Veda N et al. JCO precision oncology 2022 6e2200234
• Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for all GI Cancers?
  Hampel Heather et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 JCO2102764
• Germline genetics of prostate cancer.
  Khan Hiba M et al. The Prostate 2022 82 Suppl 1S3-S12
• The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
  Liu Alex J et al. The Prostate 2022
• Validation of the Decipher Genomic Classifier in Patients receiving Salvage Radiotherapy without Hormone Therapy after Radical Prostatectomy - An Ancillary Study of the SAKK 09/10 Randomized Clinical Trial.
  Pra A Dal et al. Annals of oncology : official journal of the European Society for Medical Oncology 2022
• Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
  A Esteva et al, NPJ Digital Medicine, June 8, 2022
• Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.
  Heise Marta et al. Cancer control : journal of the Moffitt Cancer Center 2022 2910732748211062342
• The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.
  Rakovic Kai et al. Diagnostics (Basel, Switzerland) 2022 12(5)
• Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.
  Wulczyn Ellery et al. Communications medicine 2022 110
• Genome-wide risk prediction of common diseases across ancestries in one million people.
  Mars Nina et al. Cell genomics 2022 2(4) None
• Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
  Russo A et al. ESMO open 2022 7(3) 100459
• Germline pathogenic variants in unselected Korean men with prostate cancer.
  So Min-Kyung et al. Investigative and clinical urology 2022 63(3) 294-300
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.
  Kazama Hirotaka et al. BMC cancer 2022 22(1) 470
• Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
  Anderson Ashley B et al. BMC cancer 2022 22(1) 476
• Development of a clinical polygenic risk score assay and reporting workflow.
  Hao Limin et al. Nature medicine 2022
• Artificial intelligence supporting cancer patients across Europe-The ASCAPE project.
  Tzelves Lazaros et al. PloS one 2022 17(4) e0265127

More